Tert-butyl 4-(1-aminopropan-2-yl)piperazine-1-carboxylate, 95%, 1g

5-Methyl-2-(trifluoromethyl)benzoic acid, 95.0%, 10g

E-plan EPL 10x/0.25 objective. Working distance 6.61 mm

2-FLUORO-1-(2-FLUORO-PHENYL)-ETHANONE, 95.0%, 5g

(S)-1-(2-chloro-6-fluorophenyl)propan-1-amine hcl, 95%, 100mg

GC capillary column ROTI®Cap-1, 10 m, 0.32 mm, 0.25 µm, 1 Piece(s)

4,4'-Dimethoxytrityl chloride, min. 98%, for synthesis, 100 g, glass packaging

1-Methyl-4-vinylbenzene (stabilised with TBC), 96.0%, 100g

1,4-Bis(2-chloroethyl)piperazine, 95.0%, 10g

1,4-Di-O-tosyl-2,3-O-isopropylidene-L-threitol, 98%, 250mg

2,5-Dibromo-4-fluoroaniline, 95.0%, 1g

1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 100mg

Pyridine-2,4,5-triamine, 95.0%, 1g